Market Overview:
The global drug discovery informatics market reached a value of US$ 2.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.1 Billion by 2027, exhibiting a CAGR of 11.62% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Drug discovery informatics is a technological solution used for analyzing and interpreting large volumes of biochemical data. The data is generated from the experiments conducted in clinical laboratories for research purposes and utilized for generating insights regarding the development of various drugs. It involves numerous software and hardware-based tools for sequencing, target data analysis, data visualization, docking, molecular modelling, database protection for drug discovery and development. As a result, it is widely used by healthcare institutions, pharmaceutical and biotechnology organizations and contract research organizations (CROs).
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Significant growth in the healthcare and pharmaceutical industries across the globe represents one of key the factors creating a positive outlook for the market. Furthermore, the increasing prevalence of chronic medical disorders and the escalating requirement for effective solutions to treat rare diseases are also augmenting the market growth. Drug discovery informatics is widely used by pharmaceutical organizations for the analysis of new drug entities and handling of the biological information from multiple sources. Additionally, various technological advancements, such as the development of innovative Physiologically-based Pharmacokinetic (PBPK) Simulator platforms, which aid in predicting pharmacokinetic outcomes through modeling and simulation, are acting as other growth-inducing factors. In line with this, increasing investments by government and private healthcare institutions to develop orphan drugs is also contributing to the market growth. Other factors, including the rising geriatric population, along with extensive research and development (R&D) activities in the field of bioinformatics, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global drug discovery informatics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on workflow, function, mode and end user.
Breakup by Workflow:
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Drug Discovery
- Drug Development
Breakup by Function:
- Sequence Analysis Platforms
- Molecular Modelling
- Molecular Docking
- Clinical Trial Data Management
- Others
Breakup by Mode:
Breakup by End User:
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organization (CROs)
- Others
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture Plc, Certara, Charles River Laboratories Inc., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Infosys Ltd., International Business Machines Corporation, Jubilant Biosys Limited, Oracle Corporation, PerkinElmer Inc., Selvita and Thermo Fisher Scientific Inc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Workflow, Function, Mode, End User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Accenture Plc, Certara, Charles River Laboratories Inc., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Infosys Ltd., International Business Machines Corporation, Jubilant Biosys Limited, Oracle Corporation, PerkinElmer Inc., Selvita and Thermo Fisher Scientific Inc. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global drug discovery informatics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global drug discovery informatics market?
- What are the key regional markets?
- What is the breakup of the market based on the workflow?
- What is the breakup of the market based on the function?
- What is the breakup of the market based on the mode?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global drug discovery informatics market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Drug Discovery Informatics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Workflow
6.1 Drug Discovery
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Drug Development
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Function
7.1 Sequence Analysis Platforms
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Molecular Modelling
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Molecular Docking
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Clinical Trial Data Management
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Mode
8.1 Outsourced
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 In-house
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by End User
9.1 Pharmaceutical Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Biotechnology Companies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Contract Research Organization (CROs)
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Accenture PLC
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Certara
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Charles River Laboratories Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Collaborative Drug Discovery Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Eurofins DiscoverX Products
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Infosys Ltd.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 International Business Machines Corporation
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Jubilant Biosys Limited
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Oracle Corporation
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 PerkinElmer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Selvita
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.12 Thermo Fisher Scientific Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
List of Figures
Figure 1: Global: Drug Discovery Informatics Market: Major Drivers and Challenges
Figure 2: Global: Drug Discovery Informatics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Drug Discovery Informatics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Drug Discovery Informatics Market: Breakup by Workflow (in %), 2021
Figure 5: Global: Drug Discovery Informatics Market: Breakup by Function (in %), 2021
Figure 6: Global: Drug Discovery Informatics Market: Breakup by Mode (in %), 2021
Figure 7: Global: Drug Discovery Informatics Market: Breakup by End User (in %), 2021
Figure 8: Global: Drug Discovery Informatics Market: Breakup by Region (in %), 2021
Figure 9: Global: Drug Discovery Informatics (Drug Discovery) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Drug Discovery Informatics (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Drug Discovery Informatics (Drug Development) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Drug Discovery Informatics (Drug Development) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Drug Discovery Informatics (Sequence Analysis Platforms) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Drug Discovery Informatics (Sequence Analysis Platforms) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Drug Discovery Informatics (Molecular Modelling) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Drug Discovery Informatics (Molecular Modelling) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Drug Discovery Informatics (Molecular Docking) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Drug Discovery Informatics (Molecular Docking) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Drug Discovery Informatics (Clinical Trial Data Management) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Drug Discovery Informatics (Clinical Trial Data Management) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Drug Discovery Informatics (Other Functions) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Drug Discovery Informatics (Other Functions) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Drug Discovery Informatics (Outsourced) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Drug Discovery Informatics (Outsourced) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Drug Discovery Informatics (In-house) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Drug Discovery Informatics (In-house) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Drug Discovery Informatics (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Drug Discovery Informatics (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Drug Discovery Informatics (Biotechnology Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Drug Discovery Informatics (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Drug Discovery Informatics (Contract Research Organization (CROs)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Drug Discovery Informatics (Contract Research Organization (CROs)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Drug Discovery Informatics (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Drug Discovery Informatics (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: North America: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: North America: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: United States: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: United States: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Canada: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Canada: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Asia-Pacific: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Asia-Pacific: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: China: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: China: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Japan: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Japan: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: India: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: India: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: South Korea: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: South Korea: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Australia: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Australia: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Indonesia: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Indonesia: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Others: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Europe: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Europe: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Germany: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Germany: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: France: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: France: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: United Kingdom: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: United Kingdom: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Italy: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Italy: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Spain: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Spain: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Russia: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Russia: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Others: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Latin America: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Latin America: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Brazil: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Brazil: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Mexico: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Mexico: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Others: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Middle East and Africa: Drug Discovery Informatics Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Middle East and Africa: Drug Discovery Informatics Market: Breakup by Country (in %), 2021
Figure 83: Middle East and Africa: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Global: Drug Discovery Informatics Industry: SWOT Analysis
Figure 85: Global: Drug Discovery Informatics Industry: Value Chain Analysis
Figure 86: Global: Drug Discovery Informatics Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Drug Discovery Informatics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Drug Discovery Informatics Market Forecast: Breakup by Workflow (in Million US$), 2022-2027
Table 3: Global: Drug Discovery Informatics Market Forecast: Breakup by Function (in Million US$), 2022-2027
Table 4: Global: Drug Discovery Informatics Market Forecast: Breakup by Mode (in Million US$), 2022-2027
Table 5: Global: Drug Discovery Informatics Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Drug Discovery Informatics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Drug Discovery Informatics Market: Competitive Structure
Table 8: Global: Drug Discovery Informatics Market: Key Players